SCHEMBL6583340

SCHEMBL6583340

CNC(=O)c1ccc2c(ccn2-c2ccc(F)cc2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.53
MGLL Q99685 6/20 0.49
ACSS2 Q9NR19 2/20 0.48
HPGDS O60760 1/20 0.47
SCN2B O60939 1/20 0.46
SCN1A P35498 1/20 0.46
SCN1B Q07699 1/20 0.46
SCN5A Q14524 1/20 0.46
SCN9A Q15858 1/20 0.46
EPHX2 P34913 1/20 0.45
FAAH O00519 1/20 0.43
ROCK2 O75116 1/20 0.43
PIM1 P11309 1/20 0.43
PIM3 Q86V86 1/20 0.43
HDAC3 O15379 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC2 Q92769 1/20 0.43
HDAC8 Q9BY41 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
KDM4E B2RXH2 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5108454 0.86 ROCK2 (0.46) KCNH2MGLLHPGDSROCK2PIM1
SCHEMBL122499 0.85 KCNH2 (0.57) KCNH2MGLLHPGDSEPHX2FAAH
SCHEMBL149014 0.84 KDM4E (0.54) KCNH2MGLLEPHX2KDM4EALDH1A1
SCHEMBL121755 0.83 MGLL (0.56) KCNH2MGLLHPGDSSCN9AEPHX2
SCHEMBL5112353 0.82 PPARG (0.44) ROCK2PIM1PIM3HDAC3HDAC1
SCHEMBL26583028 0.82 RIPK1 (0.47) HPGDSROCK2PIM1PIM3HDAC3
SCHEMBL6582601 0.81 KCNH2 (0.53) KCNH2MGLLHPGDSEPHX2FAAH
SCHEMBL20898076 0.79 KDM4E (0.49) KCNH2MGLLEPHX2FAAHKDM4E
SCHEMBL30365056 0.77 KCNH2 (0.49) KCNH2MGLLHPGDSEPHX2FAAH
SCHEMBL28942962 0.77 KCNH2 (0.49) KCNH2MGLLHPGDSEPHX2FAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6833376-B2 5-aminoalkyl and 5-aminocarbonyl substituted indole derivative useful for treatment of psychosis in a mammal H. LUNDBECK A/S (DK) 2004-12-21 US disclosed
EP-1214312-B1 5-AMINOALKYL AND 5-AMINOCARBONYL SUBSTITUTED INDOLES LUNDBECK & CO AS H (DK) 2004-04-14 EP disclosed
US-20020169169-A1 5-aminoalkyl and 5-aminocarbonyl substituted indoles H. LUNDBECK A/S (DK) 2002-11-14 US disclosed
EP-1214312-A1 5-AMINOALKYL AND 5-AMINOCARBONYL SUBSTITUTED INDOLES H. LUNDBECK A/S (DK) 2002-06-19 EP disclosed
WO-2001021614-A1 5-AMINOALKYL AND 5-AMINOCARBONYL SUBSTITUTED INDOLES H. LUNDBECK A/S (DK) 2001-03-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020169169-A1 5-aminoalkyl and 5-aminocarbonyl substituted indoles ADRB1, ADRA2C, ADRB2 KCNH2 79/4885MGLL 2216/4885ACSS2 1601/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.